✦ LIBER ✦

Role of paclitaxel in combined modality therapy for locally advanced non-small cell lung cancer (NSCLC): Multiinstitutional trials exploring sequential phase II studies of paclitaxel +/− carboplatin and radiation therapy (+/−hyperfractionation: HFXRT)

✍ Scribed by Choy, H; Schumaker, D; DeVore, R; Akerley, W; Johnson, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of paclitaxel, carboplati

✍ Ratanatharathorn, Vorachai; Lorvidhaya, Vicharn; Maoleekoonpairoj, Savitree; Phr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A Randomized Phase III Trial of Combined

✍ Dennis L. Carter; David Garfield; James Hathorn; Richard Mundis; Kristi A. Boehm 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 375 KB

Phase I study of concurrent real-time tu

✍ Sakakibara-Konishi, Jun; Oizumi, Satoshi; Kinoshita, Ichiro; Shinagawa, Naofumi; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A phase I/II study of Docetaxel (Taxoter

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase I/II study of daily carboplatin, 5

✍ Yoshizawa, H; Tanaka, J; Kagamu, H; Maruyama, Y; Miyao, H; Ito, K; Sato, T; Iwas 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

A phase I/randomized phase II, non-compa

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB